BioNTech plans modular vaccine factories in Africa

Published February 16, 2022 3:32 AM

By FRANK JORDANS
Associated Press

BERLIN (AP) — German vaccine maker BioNTech unveiled plans Wednesday to establish manufacturing facilities in Africa that would boost the availability of much-needed medicines on the continent. BioNTech developed the first widely approved shot against COVID-19 together with Pfizer. The modular design of the facility consists of shipping containers fitted with the equipment necessary to make the company’s mRNA-based vaccine from start to finish, save for the final step of filling doses into bottles. The first facility will be shipped to Senegal or Rwanda in the second half of this year. BioNTech aims to start production of up to 50 million doses of vaccine a year there within 12 months, pending local approval.

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

BE PART OF THE CONVERSATION

KVIA ABC 7 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.